AstraZeneca (NYSE:AZN) has shipped the first lot of Flumist Quadrivalent (Influenza Vaccine Live, Intranasal) to the U.S. for the 2020-2021 flu season. It is indicated for people between the ages of 2 and 49, although it may not prevent influenza in everyone who gets vaccinated.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.